This chapter focuses on the information of coagulation-cancer interaction in situ that
provides a basis for formulation of key hypotheses for future testing. The heterogeneity of …

It has been known for over a century that blood coagulation and fibrinolysis pathways are
activated systemically in patients with malignancy. Recent studies have revealed evidence …

Considerable progress has been made recently in understanding the mechanisms and
significance of coagulation activation in human malignancy. Neoplastic cells may activate …

It is common knowledge that blood coagulation and fibrinolysis are activated systemically in
patients with malignancy. Studies in specific in vitro and animal models of malignancy have …

Background: An association between cancer and increased blood coagula-tion has been
observed for many years. Generally, there is an equilibrium between the coagulation system …

Critical information on the nature of the coagulation-cancer interaction has been obtained
from a number of sources. In vitro/ex vivo sources of information include assays performed …

Many recent studies, derived from the early studies of normal frog leukocytes published by
Addison in 1841,'have led to the recognition that normal cells from various normal tissues …

Thrombin-catalyzed, cross-linked fibrin (XLF) formation is a characteristic histopathological
finding in many human and experimental tumors and is thought to be of importance in the …

There is a large amount of experimental evidence that supports the concept of an
association between blood coagulation and malignant disease. Since several chapters …

Cancer and Blood Coagulation: Molecular Aspects. КОРЗИНА ПОИСК НАВИГАТОР
ЖУРНАЛЫ КНИГИ ПАТЕНТЫ ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ СЛОВА …